Lead Candidate Partners with List Biotherapeutics

Lead Candidate Partners with List Biotherapeutics to Support Specialist Recruitment for $125M US Microbiome Manufacturing Facility

Lead Candidate is delighted to confirm that it is partnering with List Biotherapeutics to support specialist talent acquisition for several new pharmaceutical roles at List’s planned multi-million-dollar microbiome manufacturing facility in the USA.

List Biotherapeutics recently announced its plans to invest more than $125M into the city of Fishers, Indianapolis to develop a new 110,000 square foot lab and office space. The contract manufacturing organisation (CMO) plans to hire up to 210 local employees and has partnered with the global talent and acquisition specialist to oversee the recruitment of several key appointments.

Established in 2020, Lead Candidate provides organisations working across the global pharmaceutical outsourcing space with a new approach to hiring. Combining industry and talent acquisition expertise with high-quality client delivery Lead Candidate supports major change and growth agendas by developing long-term partnerships with ambitious organisations.

Having reached an agreement with List Biotherapeutics to support their hiring needs, Andrew Mears, Chief Executive Officer at Lead Candidate said:

“We are delighted to be working with Jonathan and the team at List Biotherapeutics on this critical phase of their journey. Our sector expertise and hiring strategies will allow us to build a team that will bring vital expertise needed today and for the businesses exciting future”.

List Biotherapeutics, whose parent company is South Korea-based Genome & Company, will invest millions in the Fishers Life Science & Innovation Park to support its global expansion plans. Cementing Indiana as an epicentre for medical innovation by adding to the vibrant life sciences sector and a first-class business climate.

Talking about the investment and subsequent hiring needs Jonathan Yongwan Jo, President and CEO of List Biotherapeutics said:

“We’re excited to establish our new manufacturing operations in Fishers, a growing life sciences hub with access to top-tier talent that can support our international expansion. Partnering with Lead Candidate gives us access to sector recruitment specialists that understand our challenges and people who are championing the talent agenda in pharma.” ?

Jonathan goes on to say:

“Our objective for the new facility is to manufacture live biotherapeutic products (LBP) for Phase 3 clinical trials and for commercial use. We aim to become the market leader and premier CMO to bring LBPs to market as we harness bacterial science to help our customers create a healthier world by leveraging List Lab’s 40-plus years of experience and expertise in the industry. Lead Candidate will be instrumental in sourcing the finest talent to drive forwards our business objectives.”

The new Fishers facility will expand the CMO’s ability to offer an end-to-end manufacturing solution from early-stage development to late-stage clinical trials and commercialization.

The team at Lead Candidate is currently working with List to hire a Project Director, Director of Process Engineering and Director of Engineering & Facilities.

Candidates are invited to review the details relating to the roles and apply via the Lead Candidate website at www.leadcandidate.com/careers.

About Lead Candidate: Headquartered in the North East of England, Lead Candidate understands the intricacies of the pharma and outsourcing space and the importance of culture and capability fit. The company’s Founders offer first-hand experience of the frustrations that surround not having the right hiring partner and provide service solutions to solve talent needs and new hire retention. Lead Candidate exists to support ambitious, growing companies in the pharmaceutical and biotech outsourcing space.

?Visit https://www.leadcandidate.com/ for more details.

About List Bio: List Biotherapeutics Inc is a wholly owned subsidiary of Genome and Co. and sister company to List Labs. List Biotherapeutics Inc, a state of the art facility in Fishers Indiana, will offer CMO services for late-stage clinical trials and commercialization of Live Biotherapeutics derived from beneficial bacteria. List Biological Laboratories (List Labs), is an established CDMO with expertise in development and cGMP manufacturing for early-stage clinical trials.

Visit: https://www.list-bio.com/

About List Labs: List Biological Laboratories, Inc, has over 40 years of experience with bacterial derived products. Developing and manufacturing one of the first Live Biotherapeutic products to enter into clinical trial, List Labs offers microbiome derived drug development experience second to none. The result is an impressive track record of successful collaborations with clients for cGMP manufacturing and a catalogue of over 100 bacterial products used in medical research and vaccine development throughout the world.

Headquartered in Campbell, CA, List Labs offers world-class expertise in drug product development including bacterial fermentation, protein purification, process development, analytical development, scale-up, and development of robust cGMP manufacturing processes for drug products used in clinical trials.

For more information, please visit https://www.listlabs.com?

About Genome & Company: Since its establishment in 2015, Genome & Company has developed the next wave of innovative drugs including anti-cancer microbiome therapeutics and novel target immune checkpoint inhibitors. Through continuing open innovations with global external collaborations and strategic investments, the company has expanded its microbiome pipeline into central nervous system disorders such as autism and continues to pioneer the market in becoming a fully integrated global healthcare group capable of research, development, and the manufacturing of first-in-class pharmaceutical modalities including microbiome.

For more information, please refer to https://www.genomecom.co.kr.

About Fishers: The city of Fishers is a suburb of Indianapolis, Indiana, and was named the #1 place to live in the US by Money Magazine in 2017. Fishers is known as smart, vibrant, and entrepreneurial and has been recognised as a destination for technology and life science industry growth. With a population of 95,310 (2019), Fishers is one of the fastest-growing communities in Indiana and has received national accolades for entrepreneurship, liveability, and safety.